0001209191-20-027672.txt : 20200507
0001209191-20-027672.hdr.sgml : 20200507
20200507162410
ACCESSION NUMBER: 0001209191-20-027672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200505
FILED AS OF DATE: 20200507
DATE AS OF CHANGE: 20200507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20856831
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-05
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
Executive Chairman
Common Stock
2020-05-05
4
M
0
24216
187.53
A
76707
D
Common Stock
2020-05-05
4
M
0
35502
96.87
A
112209
D
Common Stock
2020-05-05
4
M
0
4470
91.05
A
116679
D
Common Stock
2020-05-05
4
M
0
24349
155.57
A
141028
D
Common Stock
2020-05-05
4
S
0
4220
265.57
D
136808
D
Common Stock
2020-05-05
4
S
0
4921
266.66
D
131887
D
Common Stock
2020-05-05
4
S
0
10878
267.62
D
121009
D
Common Stock
2020-05-05
4
S
0
22613
268.86
D
98396
D
Common Stock
2020-05-05
4
S
0
15681
269.56
D
82715
D
Common Stock
2020-05-05
4
S
0
6003
270.86
D
76712
D
Common Stock
2020-05-05
4
S
0
11832
272.12
D
64880
D
Common Stock
2020-05-05
4
S
0
12849
272.97
D
52031
D
Common Stock
2020-05-05
4
S
0
5375
273.70
D
46656
D
Common Stock
440
I
401(k)
Stock Option (Right to Buy)
187.53
2020-05-05
4
M
0
24216
0.00
D
2029-02-25
Common Stock
24216
48431
D
Stock Option (Right to Buy)
96.87
2020-05-05
4
M
0
35502
0.00
D
2024-07-14
Common Stock
35502
70998
D
Stock Option (Right to Buy)
91.05
2020-05-05
4
M
0
4470
0.00
D
2026-02-01
Common Stock
4470
102806
D
Stock Option (Right to Buy)
155.57
2020-05-05
4
M
0
24349
0.00
D
2028-02-05
Common Stock
24349
48697
D
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $265.57 (range $265.16 to $266.10).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $266.66 (range $266.16 to $267.14).
Open market sales reported on this line occurred at a weighted average price of $267.62 (range $267.16 to $268.14).
Open market sales reported on this line occurred at a weighted average price of $268.86 (range $268.23 to $269.22).
Open market sales reported on this line occurred at a weighted average price of $269.56 (range $269.24 to $270.09).
Open market sales reported on this line occurred at a weighted average price of $270.86 (range $270.26 to $271.23).
Open market sales reported on this line occurred at a weighted average price of $272.12 (range $271.42 to $272.41).
Open market sales reported on this line occurred at a weighted average price of $272.97 (range $272.42 to $273.41).
Open market sales reported on this line occurred at a weighted average price of $273.70 (range $273.42 to $274.06).
Fully vested.
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-07